The stock ticker symbol ADCT represents equity shares in ADC Therapeutics SA, a commercial-stage global biotechnology enterprise listed on the New York Stock Exchange. Purchasing these shares grants public investors fractional ownership in the company's underlying corporate assets, proprietary medical research, intellectual property portfolio, and future commercial revenues derived from its advanced targeted antibody-drug conjugate oncology therapies.